BMJ 2003;327:143-147 (19 July), doi:10.1136/bmj.327.7407.143
Clinical review
Science, medicine, and the future
Cirrhosis: new research provides a basis for rational and targeted treatments
John P Iredale, professor1
1 Division of Infection, Inflammation and Repair, University of Southampton,
Southampton General Hospital, Southampton SO16 6YD
jpi@soton.ac.uk
Liver transplantation and antiviral treatments for hepatitis have improved
the outlook for many patients with liver disease. For patients with cirrhosis,
new developments herald targeted treatments
| The first 150 words of the full text of this article appear below. |
Introduction
It is an exciting time to be working in hepatology. The success
of liver
transplantation and the advances in the radiological
and endoscopic management
of portal hypertension have improved
the longevity and quality of life of
patients with liver cirrhosis.
Additionally, the development of effective
antiviral treatments
means that disease can be cured in many patients infected
with
hepatitis B and hepatitis C. However, these interventions also
serve to
highlight our current impotence in altering the underlying
fibrotic process in
many patients with liver disease. This
rather depressing perspective may soon
change: data from clinical
and laboratory based research are showing that
cirrhosis may
be reversible. By highlighting the attributes required of an
effective antifibrotic, a new dynamic model is likely to lead
to the
development of targeted treatment for liver cirrhosis.
Methods
This article is based on knowledge accrued over 13 years of
work
investigating the mechanisms of fibrosis and
. . . [Full text of this article]
Clinical impact of cirrhosis
Inflammation and repair
Pathogenesis of fibrosis
Matrix synthesis and turnover in fibrosis and cirrhosis
Models of resolution of liver fibrosis
Stellate cells as mediators of portal hypertension
Serum markers of fibrosis
The future

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Relevant Article
-
The pleasures of deep reading
- Richard Smith
BMJ 2003 327: 0.
[Extract]
[Full Text]
[PDF]
This article has been cited by other articles:
-
Wandzioch, E., Kolterud, A., Jacobsson, M., Friedman, S. L., Carlsson, L.
(2004). Lhx2-/- mice develop liver fibrosis. Proc. Natl. Acad. Sci. USA
101: 16549-16554
[Abstract]
[Full text]
-
Zhou, X., Murphy, F. R., Gehdu, N., Zhang, J., Iredale, J. P., Benyon, R. C.
(2004). Engagement of {alpha}v{beta}3 Integrin Regulates Proliferation and Apoptosis of Hepatic Stellate Cells. J. Biol. Chem.
279: 23996-24006
[Abstract]
[Full text]